Back to search
FDAFDA · Food and drugs·Recall number Z-2638-2020

DRW-0739-02: Gen 2 Posterior Chairside Splint LRUL (lower right-upper left) - Product Usage: intended to provide assistance in both the planning (pre-operative) and the surgical (intra-operative) phases of dental implantation surgery.

Published July 22, 2020 · Recall initiated: May 14, 2020

Summary

FDA records medical device Class II recall Z-2638-2020, published July 22, 2020 and initiated May 14, 2020. Recalling firm: Neocis Inc.; Status: Terminated; Reported quantity: 70 units; Lot: Work Order (lot): 1616, 1621, and 1622. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The LRUL and LLUR posterior chairside splints and LLUR anterior chairside splints may be mislabeled.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Neocis Inc.
Distributor
US Nationwide distribution including in the states of AZ, CA, FL, NY, and NH
Lot
Work Order (lot): 1616, 1621, and 1622
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was DRW-0739-02: Gen 2 Posterior Chairside Splint LRUL (lower right-upper left) - Product Usage: intended to provide assistance in both the planning (pre-operative) and the surgical (intra-operative) phases of dental implantation surgery. recalled?

Yes. FDA published recall Z-2638-2020 on July 22, 2020. Reported hazard: The LRUL and LLUR posterior chairside splints and LLUR anterior chairside splints may be mislabeled.

What should I do if I have this product?

Voluntary: Firm initiated · Letter